Penumbra, Inc.

New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Boston Scientific announces results for fourth quarter and full year 2025

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference